Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|June 28, 2002
Modification of the swern oxidation: use of a recyclable, polystyrene bound sulfoxideDerek C Cole, Joseph R Stock, Jo Anne KappelJournal of Combinatorial Chemistry|January 13, 2004
Use of design of experiments to optimize high-throughput semipreparative LC and LC/MS methodsDerek C Cole, Nicholas Pagano, Michael F Kelly, et al.Assay and Drug Development Technologies|January 10, 2008
A FLIPR-based assay to assess potency and selectivity of inhibitors of the TEC family kinases Btk and ItkJohn Douhan, Joy S Miyashiro, Xiaochuan Zhou, et al.Journal of Medicinal Chemistry|June 1, 2017
Repurposing Suzuki Coupling Reagents as a Directed Fragment Library Targeting Serine Hydrolases and Related EnzymesMarion Lanier, Derek C Cole, Yelena Istratiy, et al.Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Identification of a new class of small molecule C5a receptor antagonistsJack J Chen, Derek C Cole, Greg Ciszewski, et al.Bioorganic & Medicinal Chemistry Letters|April 25, 2008
Synthesis and PKCtheta inhibitory activity of a series of 4-(indol-5-ylamino)thieno[2,3-b]pyridine-5-carbonitrilesDiane H Boschelli, Biqi Wu, Ana Carolina Barrios Sosa, et al.The Journal of Organic Chemistry|January 27, 2007
Synthesis of pyrazolo[1,5-alpha]pyrimidinone regioisomersLori K Gavrin, Arthur Lee, Brian A Provencher, et al.Bioorganic & Medicinal Chemistry Letters|December 18, 2004
N1-arylsulfonyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives are potent and selective 5-HT6 receptor antagonistsDerek C Cole, John W Ellingboe, William J Lennox, et al.Bioorganic & Medicinal Chemistry Letters|April 7, 2009
Synthesis and PKCtheta inhibitory activity of a series of 4-indolylamino-5-phenyl-3-pyridinecarbonitrilesRussell G Dushin, Thomas Nittoli, Charles Ingalls, et al.Bioorganic & Medicinal Chemistry Letters|August 30, 2005
Conformationally constrained N1-arylsulfonyltryptamine derivatives as 5-HT6 receptor antagonistsDerek C Cole, William J Lennox, Joseph R Stock, et al.Pageof 3